The United States Food and Drug Administration (USFDA) has concluded an inspection at Lupin’s Goa facility in India. The inspection was carried out from September 6, 2021 to September 18, 2021 and closed with seven observations.
The company is confident of addressing the observations satisfactorily and is committed to be compliant with Good Manufacturing Practice standards across all its facilities.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1845.90 |
| Dr. Reddys Lab | 1270.10 |
| Cipla | 1295.15 |
| Zydus Lifesciences | 932.00 |
| Lupin | 2240.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: